A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers

American Journal of Pathology

Volumn 161, Issue 1, 2002, Pages 207-216

  Yokoi, Sana ^a,b   Yasui, Kohichiroh ^a   Saito Ohara, Fumiko ^a   Koshikawa, Katsumi ^c   Iizasa, Toshihiko ^b   Fujisawa, Takehiko ^b   Terasaki, Takeo ^d   Horii, Akira ^e   Takahashi, Takashi ^c   Hirohashi, Setsuo ^d   Inazawa, Johji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; PROTEIN P27;

AMPLICON; ARTICLE; CELL LINE; CHROMOSOME 5P; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DETERMINATION; GENE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; SKP2 GENE;

EID: 0036309975     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64172-7     Document Type: Article

References (61)

1. Biological, pathological and clinical features of small cell lung cancer
2. The changing histopathology of lung cancer: A review of 1682 cases
3. Cancer statistics, 1999
4. Clinical statistical observation of 4,931 cases with lung cancer by histological types; results of field study in Japan
5. Amplification and expression of the c-myc oncogene in human lung cancer cell lines
6. Human small-cell lung cancers show amplification and expression of the N-myc gene
7. L-myc, a new mycrelated gene amplified and expressed in human small cell lung cancer
8. Identification of novel regions of altered DNA copy number in small cell lung tumors
9. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p
10. Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations
11. Identification of frequent novel genetic alterations in small cell lung carcinoma
12. High level amplification of 1p32-33 and 2p22-24 in small cell lung carcinomas
13. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization
14. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization
15. Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: Possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon
16. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: The possible involvement of the DP1 gene in the 13q34 amplicon
17. CD44 is a potential target of amplification within the 11p13 amplicon detected in gastric cancer cell lines
18. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines
19. Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization
20. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas
21. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
22. Comparative genomic hybridization and chromosomal instability in solid tumours
23. p45(SKP2) promotes p27(Kip1) degradation and induces S phase in quiescent cells
24. p27(Kip1) ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27
25. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
26. Skp2 is oncogenic and overexpressed in human cancers
27. Role of the F-box protein Skp2 in lymphomagenesis
28. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
29. Identification of amplified DNA sequences on double minute chromosomes in a leukemic cell line KY821 by means of spectral karyotyping and comparative genomic hybridization
30. Physical ordering of three polymorphic DNA markers spanning the regions containing a tumor suppressor gene of renal cell carcinoma by three-color fluorescent in situ hybridization
31. Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for pH-positive chronic myelocytic leukemia
32. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase
33. Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells
34. Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma
35. SurvivindeltaEx3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties
36. Studies on synchronous division of tissue culture cells initiated by excess thymidine
37. Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells
38. Changes in X-ray sensitivity of HeLa cells during the division cycle
39. Experimental parameters and a biological standard for acridine orange detection of drug-induced alterations in chromatin condensation
40. CIP1/WAF1 and cyclin D proteins
41. SKP2: Evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway
42. Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication
43. Loss of cyclin dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma
44. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma
45. Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas
46. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas
47. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase
48. P27Kip1 in human lung cancers: Differential changes in small cell and non-small cell carcinomas
49. Study on growth characteristics and morphological findings of human small cell carcinoma in vitro
50. Culture and growth characteristics of human non-small cell lung cancer cells
51. Establishment and characterization of five cell lines from human small cell carcinoma
52. In vitro measurement of chemosensitivity of human small cell lung and gastric cancer cell lines toward cell cycle phase-nonspecific agents under the clinically equivalent area under the curve
53. Neuronal differentiation of oat cell carcinoma in vitro by dibutyryl cyclic adenosine 3′, 5′-monophosphate
54. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics
55. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer
56. Successive transplantation of 2 small cell (oat-cell) carcinoma of the lung and the thymus containing neuronspecific enolase into nude mice
57. Glutathione S-transferase levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity
58. Changes in cell characteristics due to culture conditions in cell lines from human small cell lung cancer
59. Relation between nucleolar size and growth characteristics in small cell lung cancer cell lines
60. Establishment of a human small cell lung cancer cell line producing a large amount of anti-diuretic hormone